UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051374
Receipt number R000058551
Scientific Title Effects of different intensity of extracorporeal shock wave therapy on upper limb spasticity in stroke patients: a randomized crossover study
Date of disclosure of the study information 2023/06/18
Last modified on 2023/11/07 19:47:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of different intensity of extracorporeal shock wave therapy on upper limb spasticity in stroke patients: a randomized crossover study

Acronym

Effects of different intensity of extracorporeal shock wave therapy on upper limb spasticity in stroke patients: a randomized crossover study

Scientific Title

Effects of different intensity of extracorporeal shock wave therapy on upper limb spasticity in stroke patients: a randomized crossover study

Scientific Title:Acronym

Effects of different intensity of extracorporeal shock wave therapy on spasticity in stroke patients

Region

Japan


Condition

Condition

stroke

Classification by specialty

Neurology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the effect of different stimulation intensities of rESWT on reducing wrist spasticity in chronic stroke patients.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

modified Tardieu scale, modified Ashworth scale; Measured before, immediately after, one week, two weeks, three weeks and four weeks after stimulation, respectively

Key secondary outcomes

pain(Visual Analog Scale); immediately after stimulation


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

High-intensity condition; 3,200 shots (1,500 shots to the forearm flexor muscle group) and 800 shots to each interphalangeal muscle of radial extracorporeal shockwave therapy, for a total of 4,700 shots at an intensity of 2.5 Bar.

Interventions/Control_2

Low-intensity condition; 3,200 shots (1,500 shots to the forearm flexor muscle group) and 800 shots to each interphalangeal muscle of radial extracorporeal shockwave therapy, for a total of 4,700 shots at an intensity of 1 Bar.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1. the first occurrence of stroke which resulted in unilateral hemiparesis
2. the modified Ashworth scale for the radiocarpal joint >=1
3. at least 12 month of stroke onset
4. the passive range of wrist joint was between 20 palmar flexion and 30 degrees of dorsiflexion

Key exclusion criteria

1. medically unstable
2. receiving muscle relaxant or anti-spastic medication
3. infraction at the cerebellum region
4. cognitive dysfunction as assessed by Hasegawa's Dementia Scale-Revised (score >20)
5. upper limb fracture or non-muscle spasm related restriction of joint movement
6. pacemaker implantation
7. coagulation disorders
8. deep vein thrombosis
9. tumour disease
10.pregnant woman
11. history of seizures and epilepsy
12. skin lesion of the upper extremity

Target sample size

18


Research contact person

Name of lead principal investigator

1st name Junji
Middle name
Last name Nakamura

Organization

Nishiyamato Rehabilitation Hospital

Division name

Department of Rehabilitation Medicine

Zip code

639-0218

Address

3-2-2 Sasayuridai, Kanmaki-cho, Kitakatsuragi-gun, Nara

TEL

0745-71-6688

Email

n.junji.0923@gmail.com


Public contact

Name of contact person

1st name Junji
Middle name
Last name Nakamura

Organization

Nishiyamato Rehabilitation Hospital

Division name

Department of Rehabilitation Medicine

Zip code

639-0218

Address

3-2-2 Sasayuridai, Kanmaki-cho, Kitakatsuragi-gun, Nara

TEL

0745-71-6688

Homepage URL


Email

n.junji.0923@gmail.com


Sponsor or person

Institute

Nishiyamato Rehabilitation Hospital

Institute

Department

Personal name



Funding Source

Organization

Kio University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Miyanaga Hospital

Address

15-10 Matsumoto-cho, Miyakonojo-city, Miyazaki

Tel

0745-71-6688

Email

n.junji.0923@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

宮永病院(宮崎県)


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 12 Month 07 Day

Date of IRB

2021 Year 02 Month 05 Day

Anticipated trial start date

2021 Year 04 Month 12 Day

Last follow-up date

2021 Year 11 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 18 Day

Last modified on

2023 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058551


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name